Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating Bryostatin-1 in combination with cytarabine for relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 trial of XL999 in acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission [Phase 1]
A Phase 1 trial evaluating dendritic cell vaccination in patients with acute myeloid leukemia in remission has been completed.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Phase 2]
Phase 2 trial evaluating a combination of cladribine, cytarabine, and idarubicin in patients with relapsed acute myeloid leukemia is reporte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years [Phase 4]
Phase 4 clinical trial update evaluating treatment for acute myeloid leukemia in patients over 65 years; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years [Phase 4]
A Phase 4 clinical trial comparing standard therapy to intensified therapy in adult acute myeloid leukemia patients aged 60 or younger has c…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: High-dose Cytarabine and Survival in AML
This is a completed clinical trial update assessing whether high-dose cytarabine affects survival in patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation [Phase 3]
This Phase 3 trial comparing peripheral blood versus bone marrow as graft sources in allogeneic stem cell transplantation has completed. It …
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation [Phase 2, Phase 3]
A randomized study comparing one versus two high-dose chemotherapy regimens followed by autologous stem cell transplantation in acute myeloi…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia [Phase 2]
Phase II trial evaluating AS1411 in combination with cytarabine for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells [Phase 1]
Phase 1 clinical trial evaluating adoptive immunotherapy with haploidentical Kir ligand-mismatched natural killer cells in high-risk acute m…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of CSL360 in acute myeloid leukemia. The trial status indicates the stud…
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) [Phase 1]
This Phase 1 trial evaluated safety, tolerability, and pharmacokinetics of AZD1152 in patients with relapsed acute myeloid leukemia. The res…
-
CLINICAL_TRIALS trial_result · 2009-09-07Clinical Trial Update: Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 study of decitabine for older patients with acute myeloid leukemia has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-07Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating donor peripheral stem cell transplantation for relapsed acute myeloid leukemia, with completed status and …
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of gemtuzumab ozogamicin in acute myeloid leukemia has completed, with Pfizer-Wyet…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML [Phase 2]
A Phase 2 trial evaluated adding sorafenib to standard frontline therapy in elderly patients with newly diagnosed acute myeloid leukemia. Th…
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 3]
A Phase 3 trial investigating T-cell and B-cell depletion in allogeneic peripheral blood stem cell transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2 [Phase 3]
A Phase 3 trial evaluating two anthracyclines and maintenance interleukin-2 for adults with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-22Clinical Trial Update: GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly [Phase 3]
This update reports on the Phase 3 GOELAMS SA4 study evaluating the role of fludarabine in treating acute myeloid leukemia in elderly patien…
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia [Phase 1]
Phase 1 dose-escalation study assessing safety and pharmacokinetics of AVE9633 as a single agent in adults with relapsed/refractory CD33-pos…
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis [Phase 2]
Phase 2 trial evaluating nebulized liposomal amphotericin B (Ambisome) for prophylaxis of invasive pulmonary aspergillosis in patients with …
-
CLINICAL_TRIALS trial_result · 2009-04-13Clinical Trial Update: Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) [Phase 3]
Clinical trial update on a Phase 3 study evaluating priming during induction and consolidation therapy in younger patients with Acute Myeloi…
-
CLINICAL_TRIALS trial_result · 2009-03-24Clinical Trial Update: Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) [Phase 1]
A Phase 1 safety and tolerance study of oral CT53518 in patients with acute myeloid leukemia has completed.